IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Fudan University
Beth Israel Deaconess Medical Center
Instituto do Cancer do Estado de São Paulo
Sun Yat-sen University
Mayo Clinic
Jonsson Comprehensive Cancer Center
Second Affiliated Hospital, School of Medicine, Zhejiang University
Gangnam Severance Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
University of California, Davis
University of Washington
St. Joseph's Healthcare Hamilton
Universitaire Ziekenhuizen KU Leuven
The First People's Hospital of Changzhou
The First People's Hospital of Changzhou
Fudan University
UMC Utrecht
Washington University School of Medicine
Chang Gung Memorial Hospital
Case Comprehensive Cancer Center
Fox Chase Cancer Center
Seattle Children's Hospital
Gustave Roussy, Cancer Campus, Grand Paris